Omer Dror, Author at Latica

Lynx.MD is now Latica: A New Healthcare Ecosystem for Advanced Collaboration

We are excited to announce that Lynx.MD is now Latica! When we founded the company in 2019 we established a mission to transform the healthcare industry by providing the best-in-class secure data ecosystem, where data scientists leverage clinical and operational data to create innovative solutions that drive value and impact. While our mission remains unchanged, our new name reflects an expanded vision to transform the healthcare industry through the power of data and collaboration.

The name “Latica” embodies our vision and values, drawing inspiration from the interconnectedness and strength of a lattice structure. It represents the foundation of our company—a robust and interconnected network that amplifies healthcare data’s potential and fosters seamless collaboration. Additionally, derived from the Latin term “latus,” meaning “broad” or “wide,” it signifies our dedication to delving into the depths of previously inaccessible data to expand healthcare knowledge by unlocking the wealth of untapped data hidden within isolated infrastructures.

At the core of Latica’s founding lies an unwavering belief in the transformative power of data-driven insights. Recognizing the need for collaboration and synergy among various healthcare stakeholders, Latica set out to create an advanced platform that effortlessly connects healthcare providers, bio, medtech and other research organizations to advance medicine through data. This innovative ecosystem fosters collaboration, knowledge exchange, and shared discoveries, powered by state-of-the-art artificial intelligence and natural language capabilities.

By harnessing the collective expertise within this interconnected network, Latica aims to drive breakthroughs in medical research, optimize treatment protocols, and catalyze transformative changes in healthcare delivery.

With our cutting-edge platform, healthcare organizations gain secure access to a centralized, permissioned, controlled environment where they can confidently share data to advance new developments in healthcare.

Our platform empowers collaborative analytics, research, and development while prioritizing security and patient privacy. By integrating advanced data analytics, machine learning, and natural language processing, Latica extracts valuable insights from both structured and unstructured data, enabling providers and researchers to drive transformative advancements.

Data investigators benefit immensely from Latica’s platform, gaining unparalleled access to diverse datasets that accelerate discoveries and foster groundbreaking advancements. They can explore new frontiers of knowledge, uncover hidden patterns that pave the way for new therapies and improved patient care.

In addition to the ability to contribute data for medical research, healthcare administrators gain powerful tools that can be used to optimize resource allocation, streamline operations, and improve overall efficiency in healthcare delivery. With enhanced visibility and insights, administrators can make informed decisions that positively impact patient outcomes while optimizing the utilization of resources.

By spearheading this transformative journey, we empower providers and researchers to unlock the full potential of interconnected data, revolutionizing healthcare and improving the lives of all.
At Latica, we firmly believe in the transformative power of data. We are dedicated to forging strong partnerships, combining our expertise with yours to unlock endless possibilities. Together, let’s pave the way for a better healthcare future informed by data.

Sincerely,
The Latica Team

AI Is Doomed Without Data

Recapping Latica CEO Omer Dror ViVE 2024 Tech Talk

Omer Dror, co-founder and CEO of Latica, presented “Data & AI: How to Overcome Data Gaps To Deliver on the Promise of AI in Healthcare.” at ViVE 2024. Dror argued that while the promise of AI in healthcare is significant, there are substantial challenges with data fragmentation, availability, and a lack of collaboration that hinder progress.

Key Takeaways

Data fragmentation and scarcity hinder the development of accurate AI models in healthcare.
Collaboration and data sharing across healthcare providers are crucial for overcoming this hurdle.
Secure data-sharing platforms like Latica‘s Trusted Data Environment can facilitate collaboration while ensuring privacy.
Widespread participation in data sharing is essential to achieve AI’s potential in healthcare and ensure health equity.

Data: The Fuel for AI Innovation

Dror highlighted the vast amount of data collected in healthcare, emphasizing that 30% of the world’s data originates from this sector. However, a significant portion of this data is unstructured and not leveraged due to fragmentation across various healthcare providers and healthcare platforms. This fragmentation makes it difficult to aggregate data for analysis and make available for AI model development.

The Challenge of Data Fragmentation

Dror explained that the fragmented nature of the US healthcare system creates challenges in collecting data across a patient’s journey. Each healthcare provider collects data specific to their touchpoint, resulting in a scattered data landscape. This fragmentation makes it challenging to create accurate predictions for various patient populations because a single healthcare system often lacks sufficient data to inform for specific conditions.

Collaboration is Key

Dror emphasized the importance of data sharing and collaboration between healthcare providers, organizations and industry. He cited research from OpenAI demonstrating the exponential increase in data size required for marginal improvements in AI model accuracy. To achieve the necessary level of accuracy for AI in healthcare, collaboration and the secure sharing of structured and unstructured data is essential.

The Role of Latica

Latica offers a Trusted Data Environment that facilitates data sharing while maintaining control and privacy. The Latica solution enables data ingestion, modeling, and de-identification to ensure secure collaboration within the healthcare ecosystem. This approach allows researchers and AI developers to access data for analysis without compromising patient privacy.

Call to Action: Collaborate with Data

Dror concluded his talk by urging the audience to participate in data collaborations. He emphasized that sharing data securely while preserving patient privacy is crucial to unlocking the true potential of AI in healthcare. Without real-world data AI is doomed to provide inadequate results. He acknowledged the challenges of data cleaning and bias inherent in data collection but stressed that collaboration is necessary to address these issues and achieve health equity through widespread AI deployment.

Finding insights in the under examined middle gray areas

As a gastroenterologist, I’ve witnessed firsthand the profound impact that effective communication can have on patient care. In our field, where every symptom and detail holds significance, the art of asking the right questions is paramount. Traditional binary inquiries, ie. do you feel better today, fall short in capturing the complexity of gastrointestinal issues and their broader implications for patient health and potential to inform research.

Consider a patient presenting with symptoms of irritable bowel syndrome. Asking a binary question such as “Do you have abdominal pain?” merely scratches the surface of their experience. By delving deeper and probing for details about the nature, severity, and triggers of their symptoms, I can glean invaluable insights that inform diagnostic evaluations and guide personalized treatment plans.

Moreover, the broader context of a patient’s health is equally essential in managing gastrointestinal conditions effectively. Binary inquiries about diet and lifestyle habits overlook the intricate interplay of factors influencing digestive function. engaging in open-ended conversations and exploring the patient’s dietary preferences, stress levels, and medical history, I can uncover underlying triggers and develop targeted interventions that address the root cause of their symptoms.

Importantly, these non-binary conversational insights are not only critical for individual patient care but also hold significant implications for advancing research in gastroenterology. By capturing the rich nuances of patient experiences, we can identify patterns, trends, and novel therapeutic targets that drive innovation and improve outcomes for all individuals affected by gastrointestinal conditions.

In this era of technological advancement, artificial intelligence (AI) and large language models (LLMs) have emerged as powerful tools in harnessing the wealth of data generated through patient-provider interactions. Natural language processing algorithms enable researchers to analyze unstructured conversational data, uncovering hidden insights that may have otherwise gone unnoticed. By leveraging AI and LLMs, researchers can accelerate the pace of discovery, facilitate knowledge dissemination, and ultimately, transform the landscape of gastroenterological care.

As an industry we have to recognize the imperative of moving beyond binary questioning and embracing a more nuanced approach to patient-centered communication. Harnessing the insights gleaned from these conversations and leveraging cutting-edge technology, we can enhance individual patient care and drive meaningful advancements in gastroenterological research. Navigating the gray areas between black-and-white answers, we can lay the groundwork for a future where every patient is provided with personalized, evidence-based care tailored to their distinct needs and experiences.

Transforming Crohn’s & Colitis Care Through Data-Driven Insights

A future of personalized care

As a gastroenterologist and co-founder of the healthcare data company, Latica, I’ve witnessed firsthand the daily challenges faced by both patients and providers navigating the complex world of Crohn’s and Colitis. These chronic inflammatory bowel diseases (IBD) are estimated to affect over 3 million Americans (1) incurring an estimated annual cost of $31 billion to the US economy. And, according to a report by the Crohn’s and Colitis Foundation (2) people with IBD incur $2,213 (3) in out-of-pocket costs per year on average, with some estimates placing this closer to $16,000 per year. While we, as providers, strive to provide the best possible care, there’s always room for improvement. And that’s where data becomes an invaluable tool, poised to revolutionize gastroenterology treatments.

Traditionally, treatment often involved assumptions based on best practices and trial-and-error using expensive medications, leaving patients in a cycle of dosage adjustments, treatment modifications and frustration. But data is changing that.

Data as a Beacon: Shining Light on Individualized Paths

Imagine being able to predict a patient’s disease course, identify early warning signs of flare-ups, or tailor treatment based on their unique genetic makeup. Data makes this possible. By analyzing vast datasets encompassing medical records, patient experiences, and even genetic factors, we can:

From Guesswork to Informed Decisions: Gone are the days of relying solely on intuition and experience. Data and analytics enable physicians to identify what works and what doesn’t, empowering them to make data-backed decisions tailored to each patient’s unique needs.
Predicting Outcomes and Tailoring Treatments: Data can help anticipate the course of a patient’s disease, allowing for proactive interventions and adjustments in treatment plans. Imagine detecting early markers of severe symptoms and customizing therapy accordingly, offering patients a better chance of remission.
Treating the Whole Person, Not Just the Disease: Data paints a holistic picture, revealing sub-types of Crohn’s and Colitis with distinct characteristics. This allows for targeted interventions, potentially avoiding unnecessary medications for certain patients, particularly young individuals who may not require aggressive treatment, yet. Regular monitoring ensures timely intervention if needed, saving patients from long-term drug use and its associated risks.
Precision Medicine: Biologics and Beyond: Data holds the key to unlocking the potential of biologics. By analyzing genetic and physical markers, we can predict which biologics are most likely to benefit each patient, maximizing treatment efficacy and minimizing side effects.

Beyond Medications: A Holistic Approach

Treating Crohn’s effectively goes beyond just addressing the disease itself. We must also consider the impact of social determinants of health, cultural background, and individual preferences. This is where data takes on a truly holistic role:

Understanding cultural nuances: By analyzing data with a cultural lens, we can provide care that respects and honors individual beliefs and values, leading to better adherence and overall well-being.
Addressing social disparities: Socioeconomic factors like access to healthcare can significantly impact disease outcomes. Data can help us identify and address these disparities, ensuring equitable care for all gastro patients.
Patient-centered decisions: Data empowers patients to be active participants in their care journey. By understanding their own data and risks, they can make informed decisions alongside their doctor, choosing treatment options that align with their values and lifestyle.

The Future is Bright: Data-Driven Solutions for Better IBD Care

The power of data is undeniable. By harnessing its insights, we can move away from trial-and-error and towards a future of personalized, data-driven Crohn’s care. This translates to:

Reduced reliance on unnecessary testing and medications: Saving both patients and the healthcare system time and money.
Improved treatment outcomes: With targeted therapies and early intervention, patients can experience fewer flare-ups and a better quality of life.
Empowered patients: Individuals become active partners in their care, making informed decisions about their health.

This data revolution is still in its early stages, but the potential is immense. By harnessing the power of information, we can move towards a future where Crohn’s and Colitis patients receive personalized, effective treatment, minimizing unnecessary interventions and maximizing their quality of life. This journey starts with embracing data as a powerful tool, not a replacement for, but a valuable partner in the hands of skilled healthcare providers and researchers. Together, we can transform the lives of millions living with Crohns’ and other gastroenterology conditions such as IBS, Fatty Liver Disase, GERD and more.

Disclaimer: This blog post is for informational purposes only and should not be construed as medical advice. Please consult with your healthcare provider for any questions or concerns you may have regarding your individual health.